Catherine Frelin

Author PubWeight™ 8.05^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential.	Cell Stem Cell	2010	1.87
2	Monitoring NF-kappa B transactivation potential via real-time PCR quantification of I kappa B-alpha gene expression.	Mol Diagn	2003	1.05
3	NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.	Int J Cancer	2009	0.99
4	Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.	Cell Signal	2005	0.98
5	Identification of gene 3' ends by automated EST cluster analysis.	Proc Natl Acad Sci U S A	2008	0.97
6	Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector.	Oncogene	2002	0.84
7	Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.	Proc Natl Acad Sci U S A	2013	0.78
8	Neurokinin-1 receptor signalling impacts bone marrow repopulation efficiency.	PLoS One	2013	0.75